360 Stocks in the S&P 500 Underperformed the Benchmark's 2024 Gain of 24%. Here's 2 High-Yielding S&P 500 Stocks to Buy in 2025, According to Wall Street.The Motley Fool • 12/29/24
Start Off the New Year With 5 Blue Chip Dividend Stocks That Pay 6% and Higher Yields24/7 Wall Street • 12/27/24
Pfizer (PFE) Suffers a Larger Drop Than the General Market: Key InsightsZacks Investment Research • 12/26/24
Dividend Harvesting Portfolio Week 199: $19,900 Allocated, $1,908.79 In Projected DividendsSeeking Alpha • 12/26/24
Pfizer's Progress on C. diff Vaccine and Pneumococcal Shot Wins Analyst ConvictionBenzinga • 12/23/24
Stocking Stuffers for Income Investors: 3 Ultra-High-Yield Dividend Stocks to Buy Before the End of 2024The Motley Fool • 12/23/24
U.S. FDA Approves Pfizer's BRAFTOVI® Combination Regimen as First-Line Treatment of BRAF V600E-Mutant Metastatic Colorectal CancerBusiness Wire • 12/20/24
Pfizer Invites Public to View and Listen to Webcast of February 4 Conference Call with AnalystsBusiness Wire • 12/19/24
Pfizer Could Soar to $36 Per Share, According to a Wall Street Analyst. Is It a Buy at Around $26?The Motley Fool • 12/19/24
Roam For the Holidays: Grindr Offers Free Access to Their Popular Travel FeatureBusiness Wire • 12/19/24
Pfizer Sets Up For A Wild Ride In 2025 Amid Looming Threats From Starboard, KennedyInvestors Business Daily • 12/18/24